Title: Full Text of SB1258
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of SB1258 ILGA.GOV SB1258 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026SB1258 Introduced 1/28/2025, by Sen. Graciela Guzmán SYNOPSIS AS INTRODUCED: 215 ILCS 200/52 new    Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.LRB104 08130 BAB 18176 b  A BILL FOR SB1258LRB104 08130 BAB 18176 b1    AN ACT concerning regulation. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Prior Authorization Reform Act is amended 5by adding Section 52 as follows: 6    (215 ILCS 200/52 new)7    Sec. 52. Prior authorization prohibited. A health 8insurance issuer may not require prior authorization for:9        (1) a prescription drug prescribed to a patient by a 10    health care professional for 6 or more consecutive months, 11    regardless of whether the prescription drug is a 12    non-preferred medication pursuant to the patient's health 13    insurance coverage;14        (2) the following prescription drugs or the 15    therapeutic equivalent approved by the United States Food 16    and Drug Administration: insulin; human immunodeficiency 17    virus prevention medication; human immunodeficiency virus 18    treatment medication; viral hepatitis medication; 19    estrogen; and progesterone; or20        (3) human immunodeficiency virus pre-exposure 21    prophylaxis and post-exposure prophylaxis drugs approved 22    by the United States Food and Drug Administration; 23    Truvada; Harvoni; Descovy; and Apretude.


================================================================================

Raw Text:
Full Text of SB1258 ILGA.GOV SB1258 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026SB1258 Introduced 1/28/2025, by Sen. Graciela Guzmán SYNOPSIS AS INTRODUCED: 215 ILCS 200/52 new    Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.LRB104 08130 BAB 18176 b  A BILL FOR SB1258LRB104 08130 BAB 18176 b1    AN ACT concerning regulation. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Prior Authorization Reform Act is amended 5by adding Section 52 as follows: 6    (215 ILCS 200/52 new)7    Sec. 52. Prior authorization prohibited. A health 8insurance issuer may not require prior authorization for:9        (1) a prescription drug prescribed to a patient by a 10    health care professional for 6 or more consecutive months, 11    regardless of whether the prescription drug is a 12    non-preferred medication pursuant to the patient's health 13    insurance coverage;14        (2) the following prescription drugs or the 15    therapeutic equivalent approved by the United States Food 16    and Drug Administration: insulin; human immunodeficiency 17    virus prevention medication; human immunodeficiency virus 18    treatment medication; viral hepatitis medication; 19    estrogen; and progesterone; or20        (3) human immunodeficiency virus pre-exposure 21    prophylaxis and post-exposure prophylaxis drugs approved 22    by the United States Food and Drug Administration; 23    Truvada; Harvoni; Descovy; and Apretude.